Previous Close | 2.9000 |
Open | 2.9000 |
Bid | 2.6500 |
Ask | 3.7000 |
Strike | 15.00 |
Expire Date | 2024-07-19 |
Day's Range | 2.9000 - 2.9000 |
Contract Range | N/A |
Volume | |
Open Interest | 1 |
Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the U.S. financial markets close.
In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Best Low Price Pharma […]
While Dynavax Technologies Corporation ( NASDAQ:DVAX ) shareholders are probably generally happy, the stock hasn't had...